AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33652438 — intervention group
Group type: COMPARATOR
Intervention: Patching - worn for 2 hours a day
Number of subjects: 40
Study 33652438 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative Flicker Glass (AFG)
Number of subjects: 40
Study 33652438 — intervention group
Group type: COMPARATOR
Intervention: Patching
Number of subjects: 40
Study 33385191 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbosacral orthosis (LSO)
Number of subjects: 20
Study 33385191 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal drawing-in maneuver (ADIM)
Number of subjects: 20
Study 33385191 — intervention group
Group type: COMPARATOR
Intervention: Without lumbar stabilization
Number of subjects: 20
Study 32980586 — intervention group
Group type: EXPERIMENTAL
Intervention: Performance-oriented task
Number of subjects: 114
Study 32980586 — intervention group
Group type: EXPERIMENTAL
Intervention: Rejection-oriented task
Number of subjects: 114
Study 35417485 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-of-care PrEP counseling with two-way SMS adherence support
Number of subjects: 0
Study 35417485 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-of-care PrEP counseling with WhatsApp group adherence support
Number of subjects: 0
Study 35417485 — intervention group
Group type: EXPERIMENTAL
Intervention: Quarterly drug-level feedback counseling (for non-responders)
Number of subjects: 0
Study 35417485 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly issue-focused counseling (for non-responders)
Number of subjects: 0
Study 35417485 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary outcome: PrEP adherence at nine months (TFV-DP ≥700 fmol/punch)
Number of subjects: 0
Study 33199423 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient supplement containing 0.8 mg of folic acid
Number of subjects: 100
Study 33199423 — intervention group
Group type: COMPARATOR
Intervention: Micronutrient supplement without folic acid
Number of subjects: 100
Study 33958863 — intervention group
Group type: EXPERIMENTAL
Intervention: Easyhaler inhaler (placebo powder)
Number of subjects: 200
Study 33958863 — intervention group
Group type: EXPERIMENTAL
Intervention: HandiHaler inhaler (placebo capsules)
Number of subjects: 200
Study 33958863 — intervention group
Group type: EXPERIMENTAL
Intervention: Easyhaler and HandiHaler inhalers
Number of subjects: 200
Study 33958863 — intervention group
Group type: EXPERIMENTAL
Intervention: In-Check Dial device
Number of subjects: 200
Study 32928276 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro-acupuncture (EA)
Number of subjects: 252
Study 32928276 — intervention group
Group type: COMPARATOR
Intervention: Sham electro-acupuncture (sham EA)
Number of subjects: 252
Study 34411291 — intervention group
Group type: EXPERIMENTAL
Intervention: Nd:YAG laser-assisted periodontal therapy (3 W, 100 μs, 20 Hz; 4 W, 600 μs, 20 Hz)
Number of subjects: 20
Study 34411291 — intervention group
Group type: COMPARATOR
Intervention: Placebo (laser off)
Number of subjects: 20
Study 32576297 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole Egg + Resistance Training (WER)
Number of subjects: 30
Study 32576297 — intervention group
Group type: COMPARATOR
Intervention: Egg White + Resistance Training (EWR)
Number of subjects: 30
Study 36314174 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal GM‐CSF administration
Number of subjects: 92
Study 32343634 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent nonpharmacological delirium prevention intervention
Number of subjects: 65
Study 32343634 — intervention group
Group type: COMPARATOR
Intervention: Waitlist sites (control)
Number of subjects: 65
Study 32343634 — intervention group
Group type: COMPARATOR
Intervention: Control sites
Number of subjects: 65
Study 32343634 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention sites
Number of subjects: 65
Study 32343634 — intervention group
Group type: EXPERIMENTAL
Intervention: Waitlist sites
Number of subjects: 65
Study 35871638 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose endotoxin (0.8 ng/kg of body weight)
Number of subjects: 114
Study 35871638 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 114
Study 34459493 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative pain neuroscience education (PNE) plus knee joint mobilization
Number of subjects: 44
Study 34459493 — intervention group
Group type: COMPARATOR
Intervention: Biomedical education plus knee joint mobilization
Number of subjects: 44
Study 34459493 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative pain neuroscience education (PNE)
Number of subjects: 44
Study 32155254 — intervention group
Group type: EXPERIMENTAL
Intervention: Group antenatal care (G-ANC)
Number of subjects: 330
Study 35012455 — intervention group
Group type: EXPERIMENTAL
Intervention: GRAde long-read sequencing approach
Number of subjects: 36
Study 35012455 — intervention group
Group type: EXPERIMENTAL
Intervention: PCR products indicating a chimeric gene
Number of subjects: 36
Study 34949967 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung rehabilitation training using the BioMaster virtual scene interactive rehabilitation training system
Number of subjects: 60
Study 34949967 — intervention group
Group type: COMPARATOR
Intervention: Routine lung rehabilitation training
Number of subjects: 60
Study 36317757 — intervention group
Group type: EXPERIMENTAL
Intervention: Test drug (biosimilar)
Number of subjects: 70
Study 36317757 — intervention group
Group type: COMPARATOR
Intervention: Reference drug (trastuzumab)
Number of subjects: 70
Study 33001851 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led intervention on video-assisted teaching regarding nature of the disease condition including diet, medication, hand and leg exercises, home care management for 30 mins.
Number of subjects: 0
Study 33001851 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control group).
Number of subjects: 0
Study 36261616 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser
Number of subjects: 40
Study 36261616 — intervention group
Group type: COMPARATOR
Intervention: Conventional
Number of subjects: 40
Study 34549535 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight gain prevention intervention
Number of subjects: 599
Study 34549535 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 599
Study 34318949 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufficient physical space
Number of subjects: 1850
Study 34318949 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufficient variety of stimulation
Number of subjects: 1850
Study 34318949 — intervention group
Group type: EXPERIMENTAL
Intervention: Fine-motor toys
Number of subjects: 1850
Study 34318949 — intervention group
Group type: EXPERIMENTAL
Intervention: Gross motor toys
Number of subjects: 1850
Study 34880026 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT) - seven sessions focused on expectancy management, cognitions regarding pain, and emotional and behavioural impact of pain
Number of subjects: 100
Study 34880026 — intervention group
Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 100
Study 34880026 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT)
Number of subjects: 100
Study 34716684 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time feedback device
Number of subjects: 900
Study 34716684 — intervention group
Group type: COMPARATOR
Intervention: Standard manual chest compression
Number of subjects: 900
Study 36076192 — intervention group
Group type: EXPERIMENTAL
Intervention: Prompt Mental Health Care (PMHC)
Number of subjects: 459
Study 34611418 — intervention group
Group type: EXPERIMENTAL
Intervention: Super bioavailable itraconazole (SBITZ) capsules
Number of subjects: 70
Study 34611418 — intervention group
Group type: COMPARATOR
Intervention: Conventional itraconazole (CITZ) capsules
Number of subjects: 70
Study 32512782 — intervention group
Group type: EXPERIMENTAL
Intervention: Longvida© (400 mg daily containing 80 mg curcumin)
Number of subjects: 80
Study 32512782 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 34016033 — intervention group
Group type: EXPERIMENTAL
Intervention: Transnational home-based elder care system
Number of subjects: 28
Study 34016033 — intervention group
Group type: EXPERIMENTAL
Intervention: Policies for formalization and legalization of care services
Number of subjects: 28
Study 32586393 — intervention group
Group type: EXPERIMENTAL
Intervention: Molecularly driven treatment selection based on biomarker profile
Number of subjects: 0
Study 32586393 — intervention group
Group type: COMPARATOR
Intervention: Current clinical practice (control)
Number of subjects: 0
Study 35691326 — intervention group
Group type: EXPERIMENTAL
Intervention: Short treatment group (500 mg intravenous imipenem-cilastatin four times a day for 72 hours)
Number of subjects: 281
Study 35691326 — intervention group
Group type: COMPARATOR
Intervention: Extended treatment group (1000 mg intravenous meropenem three times a day for ≥9 days)
Number of subjects: 281
Study 35691326 — intervention group
Group type: EXPERIMENTAL
Intervention: Short treatment group
Number of subjects: 281
Study 35691326 — intervention group
Group type: COMPARATOR
Intervention: Extended treatment group
Number of subjects: 281
Study 34512522 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine treatment plus acupuncture
Number of subjects: 120
Study 34512522 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment plus sham acupuncture
Number of subjects: 120
Study 34351555 — intervention group
Group type: EXPERIMENTAL
Intervention: S-1 plus docetaxel
Number of subjects: 0
Study 34351555 — intervention group
Group type: COMPARATOR
Intervention: S-1 alone
Number of subjects: 0
Study 34287979 — intervention group
Group type: EXPERIMENTAL
Intervention: Glepaglutide 10 mg
Number of subjects: 18
Study 34287979 — intervention group
Group type: COMPARATOR
Intervention: Glepaglutide 0.1 mg and 1 mg
Number of subjects: 18
Study 34655522 — intervention group
Group type: EXPERIMENTAL
Intervention: MVC-COV1901
Number of subjects: 3854
Study 34655522 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3854
Study 34675112 — intervention group
Group type: EXPERIMENTAL
Intervention: I-PET after four cycles of R(R)-CHOP14
Number of subjects: 513
Study 34675112 — intervention group
Group type: EXPERIMENTAL
Intervention: ΔSUVmax
Number of subjects: 513
Study 34675112 — intervention group
Group type: EXPERIMENTAL
Intervention: Deauville score (DS)
Number of subjects: 513
Study 34675112 — intervention group
Group type: EXPERIMENTAL
Intervention: aaIPI and ΔSUVmax
Number of subjects: 513
Study 34675112 — intervention group
Group type: EXPERIMENTAL
Intervention: Low/low-intermediate aaIPI combined with ΔSUVmax >70%
Number of subjects: 513
Study 34675112 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intermediate/high aaIPI combined with ΔSUVmax=70%
Number of subjects: 513
Study 32011094 — intervention group
Group type: EXPERIMENTAL
Intervention: Group VCD (Celtra Duo zirconia‐reinforced glass ceramics)
Number of subjects: 40
Study 32011094 — intervention group
Group type: EXPERIMENTAL
Intervention: Group VK (KATANA monolithic zirconia)
Number of subjects: 40
Study 32011094 — intervention group
Group type: COMPARATOR
Intervention: Group HCD (Celtra Duo zirconia‐reinforced glass ceramics)
Number of subjects: 40
Study 32011094 — intervention group
Group type: COMPARATOR
Intervention: Group HK (KATANA monolithic zirconia)
Number of subjects: 40
Study 35695389 — intervention group
Group type: EXPERIMENTAL
Intervention: Hoffman's exercise
Number of subjects: 55
Study 35695389 — intervention group
Group type: COMPARATOR
Intervention: Control group (without Hoffman's exercise)
Number of subjects: 55
Study 33140267 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser (810 nm, 1.0 W, CW, irradiation time 20 s for 3 applications) once daily for 3 days
Number of subjects: 56
Study 33140267 — intervention group
Group type: COMPARATOR
Intervention: Triamcinolone acetonide 0.1% three times a day until the lesion was healed
Number of subjects: 56
Study 33007041 — intervention group
Group type: EXPERIMENTAL
Intervention: Ugandan birthweight standard
Number of subjects: 926
Study 33007041 — intervention group
Group type: COMPARATOR
Intervention: WHO curve
Number of subjects: 926
Study 33007041 — intervention group
Group type: COMPARATOR
Intervention: Malawi curve
Number of subjects: 926
Study 33007041 — intervention group
Group type: COMPARATOR
Intervention: INTERGROWTH-21st curve
Number of subjects: 926
Study 35525255 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 1002
Study 35525255 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 1002
Study 35525255 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet (men)
Number of subjects: 1002
Study 35525255 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet (men)
Number of subjects: 1002
Study 32969330 — intervention group
Group type: EXPERIMENTAL
Intervention: Samata programme
Number of subjects: 31
Study 32969330 — intervention group
Group type: COMPARATOR
Intervention: Control communities
Number of subjects: 31
Study 33211314 — intervention group
Group type: EXPERIMENTAL
Intervention: Palbociclib plus letrozole
Number of subjects: 421
Study 33211314 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus letrozole
Number of subjects: 421
Study 34052346 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance and aerobic exercise training for 3 months upon ADT onset (N = 70)
Number of subjects: 131
Study 34052346 — intervention group
Group type: COMPARATOR
Intervention: Usual care for 3 months upon ADT onset (N = 61)
Number of subjects: 131
Study 32095845 — intervention group
Group type: EXPERIMENTAL
Intervention: Surveillance ultrasonography
Number of subjects: 2065
Study 36121127 — intervention group
Group type: EXPERIMENTAL
Intervention: MyHealthyWeight (MHW) app and a wearable activity tracker (WAT)
Number of subjects: 92
Study 36121127 — intervention group
Group type: COMPARATOR
Intervention: Standard antenatal treatments with no mHealth‐based elements (Control)
Number of subjects: 92
Study 33422365 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive alcohol and smoking cessation intervention
Number of subjects: 94
Study 33422365 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 94
Study 33422365 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful quitting of alcohol and smoking
Number of subjects: 94
Study 33227441 — intervention group
Group type: EXPERIMENTAL
Intervention: 42.6 Gy in 10 fractions (Hypofractionated RT)
Number of subjects: 32
Study 35429906 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing training during the pre-operative visit
Number of subjects: 170
Study 35429906 — intervention group
Group type: COMPARATOR
Intervention: Pre-operative visit only (Control group)
Number of subjects: 170
Study 33325562 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose (1 x 50 mg) with concomitant administration of sucrose
Number of subjects: 36
Study 33325562 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose (1 x 50 mg, 2 x 50 mg, 3 x 50 mg)
Number of subjects: 36
Study 33325562 — intervention group
Group type: COMPARATOR
Intervention: Acarbose (2 x 50 mg)
Number of subjects: 36
Study 32943031 — intervention group
Group type: EXPERIMENTAL
Intervention: e‐DA (online patient decision-aid)
Number of subjects: 352
Study 35631202 — intervention group
Group type: EXPERIMENTAL
Intervention: SAIbi educa nutrition app
Number of subjects: 104
Study 35631202 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 104
Study 33913637 — intervention group
Group type: EXPERIMENTAL
Intervention: Vadadustat
Number of subjects: 3476
Study 33913637 — intervention group
Group type: COMPARATOR
Intervention: Darbepoetin alfa (Control)
Number of subjects: 3476
Study 35750456 — intervention group
Group type: EXPERIMENTAL
Intervention: Contralateral acupuncture (CAT)
Number of subjects: 243
Study 35750456 — intervention group
Group type: COMPARATOR
Intervention: Ipsilateral acupuncture (IAT)
Number of subjects: 243
Study 35750456 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 243
Study 35396595 — intervention group
Group type: COMPARATOR
Intervention: Pump infiltration
Number of subjects: 14
Study 35396595 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual infiltration
Number of subjects: 14
Study 33507775 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin synchrony between patients and therapists
Number of subjects: 37
Study 33507775 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist-patient OT synchrony
Number of subjects: 37
Study 34775875 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet and exercise intervention
Number of subjects: 94
Study 34775875 — intervention group
Group type: COMPARATOR
Intervention: Routine health management (Control)
Number of subjects: 94
Study 34062261 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Intensity Continuous Training (LICT)
Number of subjects: 142
Study 34062261 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training plus Interval Training (MICT+IT)
Number of subjects: 142
Study 34062261 — intervention group
Group type: EXPERIMENTAL
Intervention: MICT+IT
Number of subjects: 142
Study 32050208 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentacam HR 25-picture mode
Number of subjects: 100
Study 32050208 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentacam HR 50-picture mode
Number of subjects: 100
Study 32050208 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentacam HR cornea fine mode
Number of subjects: 100
Study 32050208 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentacam HR 25-picture mode (second observer)
Number of subjects: 100
Study 32050208 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentacam HR 25-picture mode (posterior elevation Zernike term Z1)
Number of subjects: 100
Study 35232426 — intervention group
Group type: EXPERIMENTAL
Intervention: Later cord clamping (LCC) (≥ 30 s after birth)
Number of subjects: 368
Study 35232426 — intervention group
Group type: COMPARATOR
Intervention: Immediate cord clamping (ICC) (≤ 15 s after birth)
Number of subjects: 368
Study 34988583 — intervention group
Group type: EXPERIMENTAL
Intervention: Music Therapy (MT) - 3 sessions per week, parent-led, infant-directed singing supported by a music therapist; mean of 10 sessions (SD 5.95), with 83% receiving at least 6 sessions.
Number of subjects: 213
Study 34988583 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (C) - control group receiving usual care without music therapy.
Number of subjects: 213
Study 34988583 — intervention group
Group type: EXPERIMENTAL
Intervention: Music Therapy (MT) - 3 sessions per week, parent-led, infant-directed singing supported by a music therapist.
Number of subjects: 213
Study 34554243 — intervention group
Group type: EXPERIMENTAL
Intervention: Canakinumab 150 or 300 mg every 4 or 8 weeks
Number of subjects: 74
Study 32264919 — intervention group
Group type: EXPERIMENTAL
Intervention: Upfront radical surgery with total mesorectal excision (TME) followed by adjuvant FOLFOX chemotherapy
Number of subjects: 0
Study 32264919 — intervention group
Group type: COMPARATOR
Intervention: Preoperative chemoradiotherapy (PCRT) followed by TME and adjuvant chemotherapy
Number of subjects: 0
Study 32344098 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT at alternating 80% (3min) and 40% (3min) VO2peak
Number of subjects: 23
Study 32344098 — intervention group
Group type: COMPARATOR
Intervention: MICT at 60% of peak oxygen consumption (VO2peak)
Number of subjects: 23
Study 35438337 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth-delivered curriculum for cancer survivors with ostomies
Number of subjects: 15
Study 32677911 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA)
Number of subjects: 20060
Study 32677911 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20060
Study 32677911 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 20060
Study 35165274 — intervention group
Group type: EXPERIMENTAL
Intervention: sintilimab
Number of subjects: 0
Study 35165274 — intervention group
Group type: COMPARATOR
Intervention: chemotherapy
Number of subjects: 0
Study 35165274 — intervention group
Group type: COMPARATOR
Intervention: NLR ≥ 3
Number of subjects: 0
Study 33796907 — intervention group
Group type: COMPARATOR
Intervention: IV nicotine (0.0125, 0.025, 0.05, 0.1, or 0.2 mg nicotine/70 kg bodyweight)
Number of subjects: 34
Study 33796907 — intervention group
Group type: COMPARATOR
Intervention: IV nicotine (0.2 mg)
Number of subjects: 34
Study 33796907 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 34
Study 36356279 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric Assessment (GA) intervention
Number of subjects: 706
Study 36356279 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 706
Study 33487304 — intervention group
Group type: EXPERIMENTAL
Intervention: Black coffee (8 oz)
Number of subjects: 10
Study 32944971 — intervention group
Group type: EXPERIMENTAL
Intervention: Group acceptance and commitment therapy for Psychosis (G‐ACTp) delivered by trained staff and service-user experts, comprising four sessions over weeks 1-4 and two booster sessions at weeks 10 and 12.
Number of subjects: 191
Study 32944971 — intervention group
Group type: COMPARATOR
Intervention: Control group (delayed G‐ACTp after 12 weeks).
Number of subjects: 191
Study 36116025 — intervention group
Group type: EXPERIMENTAL
Intervention: Slide Compression Anatomic Plates of the Femoral Neck (SCAP-FN)
Number of subjects: 45
Study 36116025 — intervention group
Group type: COMPARATOR
Intervention: Dynamic Hip Screw systems (DHS) + Derotational Screw (DS)
Number of subjects: 45
Study 36116025 — intervention group
Group type: COMPARATOR
Intervention: Cannulated Compression Screws (CCS)
Number of subjects: 45
Study 33146769 — intervention group
Group type: EXPERIMENTAL
Intervention: TissuGlu® without drainage
Number of subjects: 0
Study 33146769 — intervention group
Group type: COMPARATOR
Intervention: Standard wound care with drain insertion
Number of subjects: 0
Study 33756298 — intervention group
Group type: EXPERIMENTAL
Intervention: Summer season body image
Number of subjects: 823
Study 33756298 — intervention group
Group type: EXPERIMENTAL
Intervention: Winter season body image
Number of subjects: 823
Study 33756298 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall seasonal body image
Number of subjects: 823
Study 34388179 — intervention group
Group type: EXPERIMENTAL
Intervention: HD-tDCS
Number of subjects: 43
Study 34388179 — intervention group
Group type: COMPARATOR
Intervention: Sham sessions
Number of subjects: 43
Study 33847780 — intervention group
Group type: EXPERIMENTAL
Intervention: Mono-J insertion for 6 hours after ureterorenoscopy
Number of subjects: 108